Aver Pharmaceuticals

Aver Pharmaceuticals was a specialty pharmaceutical company based in San Diego, California, that focused on the development and commercialization of high-value generic and branded pharmaceutical products. The company specialized in identifying and developing products with high barriers to entry, including complex formulations and niche therapeutic applications. In May 2011, Aver Pharmaceuticals was acquired by Heritage Pharmaceuticals Inc., the U.S. subsidiary of the global pharmaceutical firm Emcure Pharmaceuticals. This acquisition was strategically designed to expand Heritage's product portfolio and leverage Aver's expertise in generic drug development. Prior to its acquisition, Aver had established a robust pipeline of Abbreviated New Drug Applications (ANDAs) targeting chronic cardiovascular and metabolic conditions. Today, its legacy products and development capabilities are integrated into the broader Heritage and Emcure organizational structures.